Novo Nordisk A/S logo

Novo Nordisk A/S - Class B

STU:NOV (Denmark)   Class B
€ 122.78 (+0.75%) Mar 18
48.56
P/B:
37.82
Market Cap:
€ 547.02B ($ 594.84B)
Enterprise V:
€ 546.59B ($ 594.37B)
Volume:
4.89K
Avg Vol (2M):
2.92K
Also Trade In:
Volume:
4.89K
Avg Vol (2M):
2.92K
Market Cap € M 547,024.78
Enterprise Value € M 546,592.46
P/E(ttm) 48.56
PE Ratio without NRI 48.56
Forward PE Ratio 39.06
Price/Book 37.82
Price/Sales 17.49
Price/Free Cash Flow 58.15
Price/Owner Earnings 46.91
Payout Ratio % 0.38
Revenue (TTM) € M 31,174.00
EPS (TTM) € 2.50
Beneish M-Score -2.58
10-y EBITDA Growth Rate % 11.70
5-y EBITDA Growth Rate % 17.50
y-y EBITDA Growth Rate % 50.90
EV-to-EBIT 38.38
EV-to-EBITDA 35.26
PEG 2.77
Shares Outstanding M 4,462.23
Net Margin (%) 36.03
Operating Margin % 44.16
Pre-tax Margin (%) 45.07
Quick Ratio 0.64
Current Ratio 0.82
ROA % (ttm) 30.18
ROE % (ttm) 92.29
ROIC % (ttm) 30.03
Dividend Yield % 0.78
Altman Z-Score 13.85
Piotroski F-Score 8.00
Positive ROA Y
Positive CFROA Y
Higher ROA y-y Y
Cash flow > Earnings Y
Lower Leverage y-y Y
Higher Current Ratio y-y N
Less Shares Outstanding y-y Y
Gross Margin Increase y-y Y
Higher Asset Turnover y-y Y

STU:NOV Number of Guru Trades

To

STU:NOV Volume of Guru Trades

To

Gurus Latest Trades with STU:NOV

No Available Data

STU:NOV is held by these investors

No Available Data